TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Isofol Medical AB (publ)
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
65
|
1,150
|
2,191 |
| Financial expenses |
1
|
4
|
16 |
| Earnings before taxes |
-3,341
|
-14,356
|
-19,581 |
| EBITDA |
-3,753
|
-14,901
|
-19,837 |
| Total assets |
12,671
|
19,182
|
39,246 |
| Current assets |
12,671
|
18,821
|
38,585 |
| Current liabilities |
1,645
|
4,649
|
8,118 |
| Equity capital |
10,944
|
14,241
|
31,117 |
| - share capital |
446
|
444
|
484 |
| Employees (average) |
5
|
14
|
13 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.4%
|
74.2%
|
79.3% |
| Turnover per employee |
13
|
82
|
169 |
| Profit as a percentage of turnover |
-5140.0%
|
-1248.3%
|
-893.7% |
| Return on assets (ROA) |
-26.4%
|
-74.8%
|
-49.9% |
| Current ratio |
770.3%
|
404.8%
|
475.3% |
| Return on equity (ROE) |
-30.5%
|
-100.8%
|
-62.9% |
| Change turnover | |||
| Change turnover % |
-43%
|
-40% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
8%
|
8% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.